Peachtree Investment Advisors Inc. boosted its stake in shares of Colgate-Palmolive (NYSE:CL) by 47.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,740 shares of the company’s stock after buying an additional 3,785 shares during the quarter. Peachtree Investment Advisors Inc.’s holdings in Colgate-Palmolive were worth $699,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Moody National Bank Trust Division purchased a new position in Colgate-Palmolive during the 4th quarter valued at about $94,000. Price Capital Management Inc. purchased a new position in Colgate-Palmolive during the 3rd quarter valued at about $121,000. O Brien Wealth Partners LLC purchased a new position in Colgate-Palmolive during the 3rd quarter valued at about $123,000. IMS Capital Management increased its position in Colgate-Palmolive by 631.6% during the 3rd quarter. IMS Capital Management now owns 2,085 shares of the company’s stock valued at $140,000 after purchasing an additional 1,800 shares during the period. Finally, SRS Capital Advisors Inc. increased its position in Colgate-Palmolive by 61.1% during the 3rd quarter. SRS Capital Advisors Inc. now owns 2,475 shares of the company’s stock valued at $166,000 after purchasing an additional 939 shares during the period. Institutional investors own 74.54% of the company’s stock.

Shares of Colgate-Palmolive stock traded down $0.25 on Monday, reaching $61.85. The stock had a trading volume of 508,817 shares, compared to its average volume of 4,859,508. Colgate-Palmolive has a 1 year low of $57.41 and a 1 year high of $77.91. The company has a market cap of $53.17 billion, a P/E ratio of 21.55, a PEG ratio of 2.94 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 26th. The company reported $0.72 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The firm had revenue of $3.85 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same quarter in the previous year, the firm earned $0.73 EPS. The company’s quarterly revenue was down 3.2% compared to the same quarter last year. As a group, equities research analysts expect that Colgate-Palmolive will post 2.96 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 15th. Stockholders of record on Wednesday, January 23rd will be given a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.72%. The ex-dividend date of this dividend is Tuesday, January 22nd. Colgate-Palmolive’s payout ratio is currently 58.54%.

A number of research analysts have commented on CL shares. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Monday, October 29th. Argus reissued a “buy” rating and set a $75.00 target price (up previously from $72.00) on shares of Colgate-Palmolive in a research report on Tuesday, September 18th. Citigroup cut their target price on shares of Colgate-Palmolive from $68.00 to $63.00 and set a “hold” rating on the stock in a research report on Monday, October 29th. Wells Fargo & Co cut their target price on shares of Colgate-Palmolive from $62.00 to $58.00 and set a “market perform” rating on the stock in a research report on Monday, October 29th. Finally, SunTrust Banks downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their target price for the company from $80.00 to $65.00 in a research report on Friday, October 26th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the company. Colgate-Palmolive has a consensus rating of “Hold” and a consensus price target of $67.87.

COPYRIGHT VIOLATION NOTICE: “Colgate-Palmolive (CL) Shares Bought by Peachtree Investment Advisors Inc.” was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.watchlistnews.com/colgate-palmolive-cl-shares-bought-by-peachtree-investment-advisors-inc/2745318.html.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Further Reading: What are the components of an earnings report?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.